Acutus Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
On February 4, 2021, Acutus Medical, Inc. (Nasdaq: AFIB) announced its participation in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference. The management team will present on February 18, 2021, at 2:00 p.m. Eastern Time. Acutus focuses on diagnosing and treating cardiac arrhythmias, offering a unique range of electrophysiology products. Their commitment to innovating the field aims to enable more physicians to effectively manage patient care. Founded in 2011, Acutus is based in Carlsbad, California.
Details
News Market Reaction – AFIB
The recorded move for AFIB in the trading session of this news was -0.89%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021 at 2:00 p.m. Eastern Time.
About Acutus Medical
Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.
Investor Contact:
Caroline Corner
Westwicke ICR
D: 415-202-5678
caroline.corner@westwicke.com
Holly Windler
M: 619-929-1275
media@acutusmedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.